loader
Please Wait
Applying Filters...

Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Gusacitinib, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Gusacitinib

    DEVELOPMENTS

    PRICE INFORMATION

    DIGITAL CONTENT

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Temad- We think of world-class quality.

    2D Structure
    1. Also known as: Asn002, Asn-002, 1425381-60-7, Gusacitinib [inn], Gusacitinib [usan], En3351
    Molecular Formula
    C24H28N8O2
    Molecular Weight
    460.5  g/mol
    InChI Key
    NLFLXLJXEIUQDL-UHFFFAOYSA-N
    FDA UNII
    4801QYW816
    Gusacitinib is under investigation in clinical trial NCT02550678 (A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma).
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    2-[1-[4-[4-(4-hydroxypiperidin-1-yl)anilino]-5-oxo-6H-pyrimido[4,5-d]pyridazin-2-yl]piperidin-4-yl]acetonitrile
    2.1.2 InChI
    InChI=1S/C24H28N8O2/c25-10-5-16-6-11-32(12-7-16)24-28-20-15-26-30-23(34)21(20)22(29-24)27-17-1-3-18(4-2-17)31-13-8-19(33)9-14-31/h1-4,15-16,19,33H,5-9,11-14H2,(H,30,34)(H,27,28,29)
    2.1.3 InChI Key
    NLFLXLJXEIUQDL-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    C1CN(CCC1CC#N)C2=NC3=C(C(=O)NN=C3)C(=N2)NC4=CC=C(C=C4)N5CCC(CC5)O
    2.2 Other Identifiers
    2.2.1 UNII
    4801QYW816
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 1-(4-(4-(4-hydroxy-piperidin-1-yl)-phenylamino)-5-oxo-5,6-dihydro-pyrimido(4,5-d)pyridazin-2-yl)-piperidin-4-yl-acetonitrile

    2. 4-piperidineacetonitrile, 1-(5,6-dihydro-4-((4-(4-hydroxy-1-piperidinyl)phenyl)amino)-5-oxopyrimido(4,5-d)pyridazin-2-yl)-

    3. Asn-002

    4. Asn002

    2.3.2 Depositor-Supplied Synonyms

    1. Asn002

    2. Asn-002

    3. 1425381-60-7

    4. Gusacitinib [inn]

    5. Gusacitinib [usan]

    6. En3351

    7. 4801qyw816

    8. En-3351

    9. 2-[1-[4-[4-(4-hydroxypiperidin-1-yl)anilino]-5-oxo-6h-pyrimido[4,5-d]pyridazin-2-yl]piperidin-4-yl]acetonitrile

    10. 1-(4-(4-(4-hydroxy-piperidin-1-yl)-phenylamino)-5-oxo-5,6-dihydro-pyrimido(4,5-d)pyridazin-2-yl)-piperidin-4-yl-acetonitrile

    11. 4-piperidineacetonitrile, 1-(5,6-dihydro-4-((4-(4-hydroxy-1-piperidinyl)phenyl)amino)-5-oxopyrimido(4,5-d)pyridazin-2-yl)-

    12. Gusacitinib (usan/inn)

    13. Gusacitinib [who-dd]

    14. Chembl4594275

    15. Schembl14717111

    16. Unii-4801qyw816

    17. Gtpl10000

    18. Asn-002asn-002

    19. Bcp31675

    20. Ex-a2668

    21. Nsc818003

    22. Who 10976

    23. Nsc-818003

    24. Example 189 [wo2013028818a1]

    25. Hy-103018

    26. Asn-002; Asn 002; Asn002

    27. Cs-0023113

    28. D11676

    29. F78024

    30. 2-(1-(4-((4-(4-hydroxypiperidin-1-yl)phenyl)amino)-5-oxo-5,6-dihydropyrimido[4,5-d]pyridazin-2-yl)piperidin-4-yl)acetonitrile

    2.4 Create Date
    2013-03-21
    3 Chemical and Physical Properties
    Molecular Weight 460.5 g/mol
    Molecular Formula C24H28N8O2
    XLogP32.6
    Hydrogen Bond Donor Count3
    Hydrogen Bond Acceptor Count9
    Rotatable Bond Count5
    Exact Mass460.23352217 g/mol
    Monoisotopic Mass460.23352217 g/mol
    Topological Polar Surface Area130 Ų
    Heavy Atom Count34
    Formal Charge0
    Complexity775
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    Post Enquiry
    POST ENQUIRY